Comparing phenotypes, SP7 was significantly increased on Day 7 in osteoblasts from the type III OI patient compared to cells from the patient with moderate severity, while RUNX2 expression was significantly reduced on Day 14 in the osteoblasts from the type IV OI patient compared to type III. Here, RUNX2 is linked to osteogenesis imperfecta type 4.